Results 21 to 30 of about 4,271,269 (288)

Cost-Utility of Acromegaly Pharmacological Treatments in a French Context

Frontiers in Endocrinology, 2021
ObjectiveEfficacy of pharmacological treatments for acromegaly has been assessed in many clinical or real-world studies but no study was interested in economics evaluation of these treatments in France.
Thierry Brue, Thierry Brue, Philippe Chanson, Patrice Rodien, Brigitte Delemer, Delphine Drui, Lucile Marié, Laurène Juban, Lara Salvi, Robin Henocque, Gérald Raverot   +10 more
doaj   +1 more source

Cost-effectiveness of meningococcal vaccination of Norwegian teenagers with a quadrivalent ACWY conjugate vaccine

Human Vaccines & Immunotherapeutics, 2021
In Norway, the incidence of invasive meningococcal disease (IMD) is higher among 16–19-year-olds than in the general population. Most IMD cases among teenagers are caused by serogroup Y. Since 2011, one dose of meningococcal ACWY conjugate vaccine (MCV4)
Sara Viksmoen Watle, Lisbeth Meyer Næss, Gro Tunheim, Dominique A. Caugant, Torbjørn Wisløff   +4 more
doaj   +1 more source

A review on cost-effectiveness and cost-utility of psychosocial care in cancer patients

Asia-Pacific Journal of Oncology Nursing, 2016
Several psychosocial care interventions have been found effective in improving psychosocial outcomes in cancer patients. At present, there is increasingly being asked for information on the value for money of this type of intervention.
Femke Jansen, Valesca van Zwieten, Veerle M. H. Coupe, C Rene Leemans, Irma M Verdonck-de Leeuw   +4 more
doaj   +1 more source

Cost-effectiveness of adding empagliflozin to the standard of care for patients with heart failure with reduced ejection fraction from the perspective of healthcare system in Malaysia

Frontiers in Pharmacology, 2023
Objective: The aim of this study was to determine the cost-effectiveness of adding empagliflozin to the standard of care versus SoC alone for the treatment of patients with heart failure (HF) with reduced ejection fraction (HFrEF) from the perspective of
Siew Chin Ong, Joo Zheng Low, Joo Zheng Low, Stephan Linden   +3 more
doaj   +1 more source

Cost-effectiveness analysis of personalised versus standard dosimetry for selective internal radiation therapy with TheraSphere in patients with hepatocellular carcinoma

Frontiers in Oncology, 2022
AimsTo perform a cost-effectiveness analysis (CEA) comparing personalised dosimetry with standard dosimetry in the context of selective internal radiation therapy (SIRT) with TheraSphere for the management of adult patients with locally advanced ...
Carla Rognoni, Maria Rosa Barcellona, Irene Bargellini, Maria Grazia Bavetta, Marilena Bellò, Maurizia Brunetto, Patrizia Carucci, Roberto Cioni, Laura Crocetti, Fabio D’Amato, Mario D’Amico, Simona Deagostini, Désirée Deandreis, Paolo De Simone, Andrea Doriguzzi, Monica Finessi, Paolo Fonio, Serena Grimaldi, Salvatore Ialuna, Fabio Lagattuta, Gianluca Masi, Antonio Moreci, Daniele Scalisi, Roberto Virdone, Rosanna Tarricone, Rosanna Tarricone   +25 more
doaj   +1 more source

Cost-effectiveness and cost-utility of hypertension and hyperlipidemia collaborative management between pharmacies and primary care in portugal alongside a trial compared with usual care (USFarmácia®)

Frontiers in Pharmacology, 2022
Background: There is little experience in the economic evaluation of pharmacy/primary care collaborative health interventions using interprofessional technology-driven communication under real-world conditions.
Suzete Costa, Suzete Costa, José Guerreiro, Inês Teixeira, Dennis K. Helling, João Pereira, João Pereira, Céu Mateus   +7 more
doaj   +1 more source

Cost-utility of routine cataract surgery [PDF]

Health and Quality of Life Outcomes, 2006
If decisions on health care spending are to be as rational and objective as possible, knowledge on cost-effectiveness of routine care is essential. Our aim, therefore, was to evaluate the cost-utility of routine cataract surgery in a real-world setting.Prospective assessment of health-related quality of life (HRQoL) of patients undergoing cataract ...
Räsänen, Pirjo, Krootila, K, Sintonen, Harri, Leivo, T, Koivisto, AM, Ryynänen, Olli-Pekka, Blom, Marja, Roine, Risto   +7 more
openaire   +4 more sources

Cost-effective interventions to prevent prescription drug misuse: a systematic review

Frontiers in Public Health
BackgroundPrescription drug misuse (PDM), which involves the overprescription or inappropriate use of medications such as opioids, benzodiazepines, and stimulants, is one of the primary drivers of the opioid crisis. Identifying and understanding the most
L. Yesenia Rodríguez-Tanta, Amanda Summers, Fadia T. Shaya   +2 more
doaj   +1 more source

Establishing an Apheresis Medicine Program in a Resource‐Constrained Setting: A 5‐Year Experience From Lagos, Nigeria

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Establishing a comprehensive apheresis medicine program in a resource‐constrained setting presents significant structural, financial, and logistical challenges. Despite the growing clinical importance of apheresis services globally, published experience from sub‐Saharan Africa remains sparse.
Folasade Adelekan‐Popoola, Shakirat Gold‐Olufadi, Olufunto Olufela Kalejaiye, Abdullateef Ogala, Rasheed A. Balogun   +4 more
wiley   +1 more source

Comparative Evaluation of Hemodiafiltration, Hemoperfusion, and Standard Hemodialysis on Efficacy, Inflammatory Control, Dialysis Adequacy, and Safety in End‐Stage Renal Disease: A Prospective Observational Study

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Chronic micro‐inflammation in patients with end‐stage renal disease (ESRD) is a significant driver of cardiovascular complications and diminished quality of life. While standard hemodialysis (SHD) effectively manages small‐molecule clearance, its ability to remove medium‐to‐large uremic toxins—the primary catalysts of systemic ...
Hongwei Zuo, Weisi Dai, Jie Mao, Mei Ye, Xingshan Lu, Xiaocui Zhang   +5 more
wiley   +1 more source